Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> BACKGROUND</h3><p>Orbital exenteration (OE) is an ablative procedure used in the management of malignancies of the orbit of either primary or secondary origin. Publications evaluating this procedure have suffered from small patient numbers, heterogeneity of pathologies, and poor patient follow‐up. The purpose of this study was to assess patient outcomes in a large cohort of patients undergoing OE at a tertiary cancer center.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> METHODS</h3><p>A retrospective review was conducted of 180 consecutive patients who underwent OE at the authors' institution. Overall survival (OS) was the primary end point measured in the study. Time to locoregional recurrence (progression‐free survival [PFS]) and disease‐free survival were secondary end points.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> RESULTS</h3><p>Between the years 1993 and 2011, 180 consecutive patients received OE for craniofacial malignancy at the authors' institution. The median follow‐up for the cohort was 9.7 years (116 months). The median OS was 73 months, and the median PFS was 96 months. The presence of perineural invasion was associated with shorter OS (<i>P</i> = .01) and PFS (<i>P</i> < .01). Magnetic resonance imaging was predictive of perineural invasion (<i>P</i> < .01). Positive margins were associated with shorter PFS than negative margins (<i>P</i> < .01) but with no change in OS (<i>P</i> = .15). The overall complication rate was 15%. The major complication rate (Clavien‐Dindo 3b or greater) was 2.8% (n = 5), and there was 1 death observed (0.6%). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> CONCLUSIONS</h3><p>Used judiciously in the setting of a multidisciplinary management plan, OE for tumor control is a safe therapy.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> LAY SUMMARY</h3><ul class="unordered-list"><li>Between the years 1993 and 2011, 180 consecutive patients received orbital exenteration for craniofacial malignancy at the MD Anderson Cancer Center. The median follow‐up for the cohort was 9.7 years.</li><li>The presence of perineural invasion was associated with shorter overall survival (<i>P</i> = .01) and progression‐free survival (<i>P</i> < .01). Magnetic resonance imaging was predictive of perineural invasion (<i>P</i> < .01). </li><li>Positive margins were associated with shorter progression‐free survival than negative margins (<i>P</i> < .01). The overall complication rate was 15%. The major complication rate (Clavien‐Dindo 3b or greater) was 2.8% (n = 5). </li></ul></section>

Pathologic analysis of 83 cases with orbit neoplasm

Statistical Analysis of 9 056 Cases of Oral and Maxillofacial Tumors, Cysts and Tumor-Like Lesions in 52 Years

Orbital Exenterations: Experience of 189 Cases

Microsurgical Resection of Sellar Tumors Via Lateral Supraorbital Approach:Clinical Analysis of 20 Cases

Clinical and pathological analysis of the olfactory neuroblastoma

[A clinicopathological classification analysis of ocular mass lesions in 7 910 cases].

Orbital Lesions: A bird's eye view of series of 2068 cases in 27 years in a tertiary care hospital in Pakistan

Orbital malignant peripheral nerve sheath tumor: A case report and review

Classification and clinicopathological analysis of orbital lymphoma

[Retrospectively Analysis of Diagnosis and Treatment of the Orbital Neurilemomas].

Clinicopathological Analysis of 719 Pediatric and Adolescents’ Ocular Tumors and Tumor-Like Lesions: a Retrospective Study from 2000 to 2018 in China

Operative Treatment for Orbitocranial Tumors

Orbital granular cell tumours: clinical and pathologic characteristics of six cases and literature review

Clinicodemographic profile of orbital exenteration in a tertiary eye care center – A 20-year experience

Obital Tumors:A Report of 80 Cases

Management of Orbital Contents in Advanced Malignant Maxillary Sinus Tumors with Orbital Invasion

[Analysis of the Results of Surgical Management of Orbital Osteoma].

Endoscopic Endonasal Intraconal Approach for Orbital Tumor Resection: Case Series and Systematic Review

Outcomes of orbital exenteration for craniofacial lesions

Orbital Oncocytic Carcinoma: A Comprehensive Case Series and Literature Review

Global Incidence and Prevalence of Malignant Orbital Tumors